Target intelligence / Profile preview

High mobility group nucleosome binding domain 1 pseudogene 5 (HMGN1P5)

Target
HMGN1P5
Molecular classification
Other, Pseudogene
01

Overview

High mobility group nucleosome binding domain 1 pseudogene 5 (HMGN1P5) is classified as a pseudogene, which means it is a DNA sequence similar to the functional HMGN1 gene but is nonfunctional and does not produce a protein product[2][5]. Pseudogenes like HMGN1P5 may sometimes be transcribed into noncoding RNA, potentially acting as regulators of their protein-coding gene family through mechanisms such as microRNA binding competition or modulation of mRNA stability, although there is no direct functional data for HMGN1P5 in the literature[1][2]. There is no evidence to indicate that HMGN1P5 acts as a receptor, enzyme, transporter, or other canonical therapeutic target, nor that it interacts with known drugs or serves as a biomarker. It is considered a member of the pseudogene molecular class[4][5]. Key points: HMGN1P5 does not encode a functional protein and is not considered a valid therapeutic or diagnostic target. It is not associated with any drugs, mechanisms of action, or biomarkers. Pseudogenes as a class can function as regulators in gene networks, but there are no reported specific functions or disease associations for HMGN1P5 specifically[1][2].

Other names
HMGN1P5
02

Biological functions

Potential regulator of gene expression (by competing for microRNAs or RNA-binding proteins)Source of noncoding RNA (if transcribed)May play a role in regulation of parental gene, but no direct evidence specific to HMGN1P5
03

Disease associations

Other (Pseudogenes in general may have regulatory roles in cancer and other diseases[1][2], but no specific evidence for HMGN1P5)

Beyond the preview

Go deeper on High mobility group nucleosome binding domain 1 pseudogene 5 (HMGN1P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 5 (HMGN1P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call